According to a new market report published by Transparency Market Research “Mice Model Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023”, the global mice model market was valued at USD 1.01 billion in 2013 and is anticipated to expand at a CAGR of 6.4% from 2015 to 2023 to reach USD 1.75 billion by 2023.
Browse the full report at
Mice have been one of the most important research tools for basic and applied research in biomedical sciences and continues to grow at a rapid rate. Besides providing precise correlation with human condition, the major advantage of mice models is the prospect of exploring precise gene-specific functions and various molecular events in a living organism. Combining mice models with advanced imaging technologies provide unique opportunities to understand the etiology and pathophysiology of human diseases. Furthermore, mice have been widely used in biomedical research to discover human diseases and to evaluate new drug candidates. Mouse research has led to major advances in treating a number of diseases and conditions. For example, experiments on mice models resulted in efficacious treatments for acute promyelocytic leukemia, or APL, which was largely terminal.
Browse Press Release Of This Report:- http://www.transparencymarketresearch.com/pressrelease/mice-model-market.htm
The global mice model market has been segmented on the basis of model type, specialty, services, and geography. Based on model type, the market has been segmented into hybrid/congenic, transplantation mouse, transgenic, knockout, carcinogen-induced and spontaneous mouse, outbred, inbred, and conditioned/surgically modified. Inbred was the largest segment of the global mice model market in 2014 due to advantages such as cost effectiveness and data reproducibility. Moreover, the hybrid/congenic segment is expected to expand at the highest CAGR during the...